Sony Olympus Medical Solutions: Negative Net Worth and Loan Recovery Risk
First written in FY2017. 5 of 7 entries say "Mitigated", first in FY2019. Latest entry: FY2024.
Olympus moved to the "Worse" side of this theme in 2017, 6 years before the typical company in this theme (2023).
The whole theme swung hardest in 2022: 11 of 19 companies on the "Worse" side.
14 other companies' latest entry also says "Mitigated".
- FY2024MitigatedAnnual report
「Reversal following the recovery in the financial condition of Sony Olympus Medical Solutions Co., Ltd.: ¥1,024 million」
Following the recovery in the financial condition of the affiliate, the provision related to Sony Olympus Medical Solutions was reversed. - FY2024MitigatedAnnual report
「Reversal following the recovery in the financial condition of Sony Olympus Medical Solutions Co., Ltd.: ¥1,024 million」
Following the recovery in Sony Olympus Medical Solutions' financial condition, the provision for losses on the business of an affiliated company was reversed by ¥1,024 million. - FY2021MitigatedAnnual report
「The company had net liabilities of ¥10,194 million as of the end of March 2021.」
Sony Olympus Medical Solutions' net liabilities decreased from ¥11,810 million in the previous fiscal year to ¥10,194 million. - FY2020MitigatedAnnual report
「The company had net liabilities of ¥11,810 million as of the end of March 2020.」
Sony Olympus Medical Solutions' net liabilities decreased from ¥12,955 million in the previous fiscal year to ¥11,810 million. - FY2019MitigatedAnnual report
「The company had net liabilities of ¥12,955 million as of the end of March 2019.」
Sony Olympus Medical Solutions' net liabilities decreased from ¥14,184 million in the previous fiscal year to ¥12,955 million. - FY2018WorsenedAnnual report
「The company had net liabilities of ¥14,184 million as of the end of March 2018.」
Sony Olympus Medical Solutions' net liabilities increased from the previously reported ¥14,077 million to ¥14,184 million. - FY2017MaterialisedAnnual report
「The company had net liabilities of ¥14,077 million as of the end of March 2017.」
The equity-method affiliate had net liabilities of ¥14,077 million, and an allowance for doubtful accounts of ¥6,909 million was recognized for loans to the company.